You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

June 2001

Volume 51, Issue 6

Pages 507–635

  1. Review series

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Pulse wave analysis (pages 507–522)

      Michael F. O'Rourke, Alfredo Pauca and Xiong-Jing Jiang

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01400.x

    2. You have free access to this content
      Stopping rules for phase II studies (pages 523–529)

      Nigel Stallard, John Whitehead, Susan Todd and Anne Whitehead

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01381.x

  2. Pharmacokinetics

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
    2. You have free access to this content
      Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria (pages 541–546)

      Tran Quang Binh, Kenneth F. Ilett, Kevin T. Batty, Timothy M. E. Davis, Nguyen Canh Hung, Shane M. Powell, Le Thi Anh Thu, Huynh Van Thien, Hoang Lan Phuöng and Vu Duong Bich Phuong

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.1365-2125.2001.01395.x

    3. You have free access to this content
  3. Population pharmacokinetics

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome—a population pharmacokinetic study (pages 557–565)

      Stéphane Mouly, Guy Aymard, Jean-Paul Tillement, Charles Caulin, Jean-Francois Bergmann and Saik Urien

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01389.x

    2. You have free access to this content
      Population pharmacokinetics of carbamazepine in Singapore epileptic patients (pages 567–576)

      Eli Chan, How Sung Lee and Swee Shan Hue

      Article first published online: 27 MAR 2003 | DOI: 10.1046/j.0306-5251.2001.01396.x

  4. Pharmacodynamics

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab (pages 577–582)

      J. Graff, D. Andries, M. Elsner, D. Westrup, S. Bassus, N. Franz, U. Klinkhardt and S. Harder

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.1365-2125.2001.01392.x

    2. You have free access to this content
  5. Drug interactions

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers (pages 591–600)

      Yasmin Khaliq, Keith Gallicano, Christine Tisdale, Germain Carignan, Curtis Cooper and Anne McCarthy

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.1365-2125.2001.01393.x

  6. Pharmacovigilance

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Public health impact of adverse bone effects of oral corticosteroids (pages 601–607)

      T. P. Van Staa, L. Abenhaim, C. Cooper, B. Zhang and H. G. M. Leufkens

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.bjcp.1385.x

    2. You have free access to this content
      A 6-month large-scale study into the safety of tamsulosin (pages 609–614)

      M. C. Michel, H.-U. Bressel, M. Goepel and H. Rübben

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01388.x

  7. Drug utilization

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Drug therapy in the elderly: what doctors believe and patients actually do (pages 615–622)

      I. Barat, F. Andreasen and E. M. S. Damsgaard

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01401.x

  8. Short reports

    1. Top of page
    2. Review series
    3. Pharmacokinetics
    4. Population pharmacokinetics
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacovigilance
    8. Drug utilization
    9. Short reports
    1. You have free access to this content
      Recording previous adverse drug reactions—a gap in the system (pages 623–626)

      Gillian M. Shenfield, Tanya Robb and Margaret Duguid

      Article first published online: 16 JUL 2009 | DOI: 10.1111/j.1365-2125.2001.01380.x

    2. You have free access to this content
      Is cytochrome P450 2C9 genotype associated with NSAID gastric ulceration? (pages 627–630)

      Jennifer H. Martin, Evan J. Begg, Martin A. Kennedy, Rebecca Roberts and Murray L. Barclay

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01398.x

    3. You have free access to this content
      The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals (pages 631–635)

      C. H. W. Koks, K. M. L. Crommentuyn, R. M. W. Hoetelmans, D. M. Burger, P. P. Koopmans, R. A. A. Mathôt, J. W. Mulder, P. L. Meenhorst and J. H. Beijnen

      Article first published online: 24 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01409.x

SEARCH

SEARCH BY CITATION